about
Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary interventionTong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary interventionDistinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.Genetics of coronary artery disease and myocardial infarctionBiodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical resultsRecent advances in drug eluting stentsAn implantable compound-releasing capsule triggered on demand by ultrasound.Oral antiplatelet therapy and percutaneous coronary interventionThe tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stressesUnconstrained recovery characterization of shape-memory polymer networks for cardiovascular applicationsVariation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary interventionVascular smooth muscle polyploidization as a biomarker for aging and its impact on differential gene expressionLow dose rapamycin exacerbates autoimmune experimental uveitisQuantitative trait locus analysis of neointimal formation in an intercross between C57BL/6 and C3H/HeJ apolipoprotein E-deficient mice.Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.A multicentre randomized clinical trial on efficacy and safety of huxin formula in patients undergoing percutaneous coronary intervention.Concentration-dependent differential effects of udenafil on viability, proliferation, and apoptosis in vascular endothelial and smooth muscle cells.Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.Delivery of plasmid DNA to vascular tissue in vivo using catheter balloons coated with polyelectrolyte multilayers.Fabrication of nonbiofouling metal stent and in vitro studies on its hemocompatibility.The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth.Multi-vessel coronary disease and percutaneous coronary interventionp53Arg72Pro polymorphism of tumour suppressor protein is associated with luminal narrowing after coronary stent placement.Physiologically relevant oxidative degradation of oligo(proline) cross-linked polymeric scaffoldsVariations in the use of an innovative technology by payer: the case of drug-eluting stents.Vascular smooth muscle cell migration: current research and clinical implications.Early experiences and clinical implications of drug-eluting stents: part 1.Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study.Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetesDrug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.The drug-based pipeline against restenosis.Modelling intravascular delivery from drug-eluting stents with biodurable coating: investigation of anisotropic vascular drug diffusivity and arterial drug distribution.The effect of paclitaxel-eluting covered metal stents versus covered metal stents in a rabbit esophageal squamous carcinoma model.Drug-eluting stents: from evidence to policy.Cells, cytokines and cellular immunity in the pathogenesis of fibroproliferative vasculopathies.High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents.Microfabrication-compatible nanoporous gold foams as biomaterials for drug delivery.The mTOR pathway in the control of protein synthesis.Nanocoating for biomolecule delivery using layer-by-layer self-assembly.
P2860
Q24187868-C0B3804B-4226-41B9-A500-00EC92F48074Q24202716-DAF7BACA-B2CA-4D65-8D89-A961557B20ACQ24519078-985970C1-04D8-4F44-B902-5A9F792B33ADQ26769994-DD821D0D-DE31-4406-8A48-26FF8628B66BQ26864540-1A391747-102E-4C12-8716-7F5275212C92Q27025538-0372965A-C6B6-462A-9F79-A8AE651070D5Q27333679-A076872B-3AF4-41D2-8868-CFF308B27F74Q28217724-5019896C-4260-4240-9D6A-1FE292D556CCQ28240102-0E5BCD90-A9F2-4395-9668-18AE3A03C7F3Q28287871-7ED54B8A-086A-4775-88EB-17D340BCE361Q28391736-F6A2DF0E-FE05-4461-AC14-8267A06DF059Q28568654-3DB3E50A-A811-4E69-8571-3D9DAD1B913DQ28730115-A36D3EBB-E519-4DDB-AF1B-2341A1A87C17Q30438881-CE527C98-8E64-4466-8047-61FFA011B915Q31119076-18D54DF3-12FD-472A-995E-7E3C51CC41CEQ33757831-C7733AAD-1F12-4624-9175-49A19A2676CDQ33809405-4E22EF79-9462-4D15-B07B-30D541F7104DQ34234296-B150C3FB-7D90-49E1-B6F8-C7F76627DC90Q34349030-7115A773-6EBB-4EBD-BFA8-61B1464998F6Q35049945-5688784F-0351-4C55-9878-957F1176F34FQ35537902-577E2448-F132-44D9-8F40-524B16E1C8C2Q35582152-55B76DB2-2ACC-4275-9E4A-FD145128A31EQ35582875-917924A8-91AD-44FF-A3BB-F434C1DCCFCAQ35612959-821816E2-A22B-4D8E-8BBC-949030FFD1C8Q35619214-7DF0C2E7-4E5B-4D39-9E4B-14E1B8346513Q35647930-8C77DE96-340D-4B3A-8B52-1BAF5C930B6FQ35651217-B4ADC6AF-9941-4CC4-BA72-32050F8D2C14Q35771937-9F75274D-988B-4D56-8BCA-C3401216FEB0Q35772244-F9D9D6BD-E7A3-470B-9BD0-319F3AAD7A4AQ35945466-FD403ECF-1B85-4EB5-AD9E-ADBA9258FC48Q36040667-114682A5-ED7A-449B-9487-F155461623FAQ36066019-8C29DDB5-8238-4735-988B-41EFD6EB8DB6Q36233611-AC0A909A-55A7-4871-863B-D7E5043194C1Q36295562-2A1F21D1-5280-408A-BD83-D04551996EEBQ36314909-6D2727C4-AEF5-4A80-B53E-43FD92100B7AQ36333439-6FFAECEA-DA53-41FE-8E78-2C4A5FB3EA91Q36392994-A355319B-5412-46E9-BB2B-69AB93F66A53Q36494843-4EBB9974-62E4-4EFD-B060-C1F092C1D184Q36600753-C1BB2E5E-D694-4695-93A7-D64203571CACQ36807989-8EF3080A-9133-438D-9AEC-560A55D1A328
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Drug-eluting stents in vascular intervention.
@ast
Drug-eluting stents in vascular intervention.
@en
type
label
Drug-eluting stents in vascular intervention.
@ast
Drug-eluting stents in vascular intervention.
@en
prefLabel
Drug-eluting stents in vascular intervention.
@ast
Drug-eluting stents in vascular intervention.
@en
P1433
P1476
Drug-eluting stents in vascular intervention.
@en
P2093
Rossella Fattori
Tommaso Piva
P304
P356
10.1016/S0140-6736(03)12275-1
P407
P577
2003-01-01T00:00:00Z